Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| B.Braun Surgical SA | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The goal of this retrospective study is to identify the incidence of hernia recurrence following the application of Histoacryl® Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. All adult patients who underwent laparoscopic inguinal hernia repair with Histoacryl® Lapfix - Cannula in the period June 2018 - March 2021 at Hospital San Juan de Dios will be analysed. The investigator team will access electronical medical records for the cohort of patients identified.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Histoacryl Lapfix | Histoacryl Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| hernia repair surgery | Device | In recent years, atraumatic mesh fixation with tissue adhesive has increasingly become the method of choice. It is the recommended mesh fixation method by the International Hernia Society Guidelines. In this study patients with inguinal hernia are treated by placing a prosthetic mesh in one of the layers of the abdominal wall to cover the weakness, the mesh is fixed by Histoacryl LapFix, |
| Measure | Description | Time Frame |
|---|---|---|
| Hernia recurrence rate | Describe the incidence of hernia recurrence following the application of Histoacryl® LapFix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. The incidence of hernia recurrence is documented from the medical records until 6 months postoperatively. | until 6 months postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Delayed tissue adhesive polymerization | The polymerization time of Histoacryl® (about 30 seconds) takes longer than expected. | intraoperatively |
| Intraoperative bleeding requiring therapeutic measures |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients (≥18 years old) treated in the period June 2018 to March 2021 at the Hospital San Juan de Dios for laparoscopic mesh fixation with Histoacryl Lapfix - Cannula after inguinal hernia repair surgery.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital San Juan de Dios | Santa Cruz de Tenerife | Tenerife | 38001 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006552 | Hernia, Inguinal |
| ID | Term |
|---|---|
| D046449 | Hernia, Abdominal |
| D006547 | Hernia |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
Bleeding that requires additional measures than normal practice for stopping the hemorrhage.
| intraoperatively |
| Organ injury | Cumulative Number of patients suffering from Injury of an organ adjacent to the defect. | intraoperatively |
| Hernia recurrence | Cumulative Number of Hernia recurring again after repair | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Mesh migration | Cumulative Number of patients in whom Mesh has moved from its original position | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Adhesions | Cumulative Number of patients in whom tissue is adhered and allows no physiological movement | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Erosion | Cumulative Number of patients suffering from a mesh erosion into the bladder/urethra include painful voiding, urinary frequency, urgency, hematuria, recurrent urinary tract infection, urinary calculi and urinary fistula. | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Meshoma formation | Cumulative Number of patients suffering from a wrinkling of the mesh that causes pain or hernia recurrence. Nerve entrapment or damage. Rejection of the mesh implant. | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Tack hernias | Cumulative Number of patients requiring tack fixation was needed | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Surgical Site Infection (superficial, deep, intraabdominal) | Cumulative Number of patients suffering from Surgical Site Infection classified according on Center for Disease Control and Prevention criteria (A1: superficial, A2: deep, A3: organ/space) | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Hematoma | Cumulative Number of patients suffering from a solid swelling of clotted blood within the tissues. | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Seroma | Cumulative Number of patients suffering from a mass or lump caused by a buildup of clear fluid in a tissue, organ or body cavity | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Hemorrhage | Cumulative Number of patients suffering from an escape of blood from a ruptured blood vessel. | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Orchitis | Cumulative Number of patients suffering from inflammation of the testicles | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Other Adverse Event | Cumulative Number of any other adverse event not mentioned. | at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months |
| Reintervention | Patient requiring to be operated again for any reason. | until 6 months postoperatively |
| Mesh repositioning or removal | Patient requiring being operated again for repositioning or removal of the Mesh | until 6 months postoperatively |
| Acute or chronic pain | pain persisting beyond 6 months postoperatively re-quiring analgesic treatment | until 6 months postoperatively |